Examkin

Question

Difficulty: Very hardOrdering Imaging Studies

A 60-year-old female undergoes an abdominal ultrasound to evaluate vague right upper quadrant discomfort. The gallbladder is normal, but the sonographer incidentally notes a 3.43.4 cm homogeneous, well-circumscribed solid mass in the left adrenal gland. The patient has no significant past medical history, no history of malignancy, and normal vital signs. Physical examination reveals no stigmata of endocrine excess. Comprehensive biochemical evaluation (including plasma free metanephrines, a 11-mg overnight dexamethasone suppression test, and an aldosterone-to-renin ratio) is entirely within normal limits. The physician decides to proceed with step-wise radiologic characterization to definitively rule out a primary adrenal malignancy.

Arrange the following imaging modalities in the correct hierarchical diagnostic sequence used to characterize an indeterminate adrenal incidentaloma, starting with the standard first-line study and progressing to advanced problem-solving modalities for persistently equivocal lesions.

  1. 1Unenhanced computed tomography (CT) of the adrenal glands
  2. 2Contrast-enhanced CT of the adrenal glands with 15-minute delayed washout imaging
  3. 3Magnetic resonance imaging (MRI) of the abdomen with chemical shift sequences
  4. 418F-FDG positron emission tomography (PET) scan

Answer

The correct algorithmic sequence for evaluating an indeterminate adrenal incidentaloma is: Unenhanced CT (initial triage), followed by Contrast-enhanced CT with delayed washout imaging, then Chemical shift MRI, and finally 18F-FDG PET scan.
The established algorithmic approach to adrenal incidentalomas strictly prioritizes cost-effective, high-yield tests first. Unenhanced CT acts as the universal gatekeeper (lipid-rich vs. non-lipid). Adrenal protocol washout CT follows for lipid-poor lesions. Chemical shift MRI acts as a secondary problem-solving tool for indeterminate washout, and FDG-PET is reserved for highly suspicious lesions failing all prior characterization before surgery.

Step-by-Step Solution

1
Select the initial imaging study to evaluate the baseline tissue density of the mass.
Unenhanced CT of the adrenal glands.
Lipid-rich adenomas account for the vast majority of adrenal incidentalomas. An unenhanced CT showing ≤10\leq 10 HU is highly specific for a benign adenoma and requires no further workup.
2
Determine the next imaging step if the mass is dense (>10> 10 HU).
Contrast-enhanced CT with 15-minute delayed washout imaging.
Malignant lesions retain contrast, whereas benign adenomas rapidly wash out contrast. An absolute washout >60%> 60\% or relative washout >40%> 40\% diagnoses a lipid-poor adenoma.
3
Identify the problem-solving modality for lesions with indeterminate CT washout.
Chemical shift MRI.
MRI utilizes the differing resonance frequencies of protons in water and fat. A signal intensity drop on out-of-phase imaging compared to in-phase imaging definitively identifies microscopic intracellular lipid, confirming a benign etiology.
4
Select the final non-invasive imaging modality for a persistently suspicious or indeterminate mass.
18F-FDG PET scan.
If standard structural and chemical shift imaging fail to characterize the lesion, a PET scan evaluates the metabolic behavior. High FDG avidity strongly suggests adrenocortical carcinoma or metastasis, prompting surgical adrenalectomy.

Key Concept

The step-wise hierarchical imaging algorithm for characterizing adrenal incidentalomas.
Estimated Time:2m 0s
Rate this question

Topics

Ordering Imaging Studies

More questions from this topic